Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 2/20 | 0.42 |
| ▸ | TSHR | P16473 | 2/20 | 0.42 |
| ▸ | ADRB2 | P07550 | 1/20 | 0.40 |
| ▸ | ADRB1 | P08588 | 1/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.39 |
| ▸ | HTT | P42858 | 2/20 | 0.39 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.39 |
| ▸ | GAA | P10253 | 1/20 | 0.39 |
| ▸ | MEN1 | O00255 | 1/20 | 0.39 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.38 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.38 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.38 |
| ▸ | ADRA2A | P08913 | 2/20 | 0.38 |
| ▸ | ADRA2B | P18089 | 1/20 | 0.38 |
| ▸ | ADRA2C | P18825 | 1/20 | 0.38 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.38 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.38 |
| ▸ | LMNA | P02545 | 1/20 | 0.36 |
| ▸ | NAMPT | P43490 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22785900 | 1.00 | CYP3A4 (0.42) | CYP3A4TSHRADRB2ADRB1ALDH1A1 | |
| SCHEMBL22785947 | 1.00 | CYP3A4 (0.42) | CYP3A4TSHRADRB2ADRB1ALDH1A1 | |
| SCHEMBL5958160 | 0.98 | CYP3A4 (0.41) | CYP3A4TSHRADRB2ADRB1ALDH1A1 | |
| SCHEMBL22785946 | 0.96 | CYP3A4 (0.42) | CYP3A4TSHRADRB2ADRB1ALDH1A1 | |
| SCHEMBL5688224 | 0.96 | CYP3A4 (0.42) | CYP3A4TSHRADRB2ADRB1ALDH1A1 | |
| SCHEMBL22785904 | 0.96 | CYP3A4 (0.42) | CYP3A4TSHRADRB2ADRB1ALDH1A1 | |
| SCHEMBL9392874 | 0.79 | PDE4D (0.40) | CYP3A4ALDH1A1KMT2AHTTHSP90AA1 | |
| SCHEMBL4885085 | 0.77 | ADRB2 (0.44) | CYP3A4TSHRADRB2ADRB1ALDH1A1 | |
| SCHEMBL25594516 | 0.77 | CYP3A4 (0.33) | CYP3A4TSHRADRB2ADRB1ALDH1A1 | |
| SCHEMBL20933087 | 0.77 | ALDH1A1 (0.37) | CYP3A4ADRB2ADRB1ALDH1A1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118340754-B | Compound for treating heart failure and related diseases and application thereof | 源道医药(苏州)有限公司 | 2025-03-11 | — | — | CN | disclosed |
| CN-119490387-A | Compounds for the treatment of pain-related diseases | 源道医药(苏州)有限公司 | 2025-02-21 | — | — | CN | disclosed |
| CN-118340754-A | Compound for treating heart failure and related diseases and application thereof | 源道医药(苏州)有限公司 | 2024-07-16 | — | — | CN | disclosed |
| EP-3906969-A1 | ANTIHYPERTENSIVE POLYOL COMPOUND AND DERIVATIVE THEREOF | East China University of Science and Technology (CN) | 2021-11-10 | — | — | EP | disclosed |
| US-20060122064-A1 | Amides and method for plant diseases control with the same | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2006-06-08 | — | — | US | disclosed |
| US-20060122065-A1 | Amide compound and method of controlling plant disease with the same | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2006-06-08 | — | — | US | disclosed |
| EP-1640360-A1 | AMIDES AND METHOD FOR PLANT DISEASE CONTROL WITH THE SAME | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2006-03-29 | — | — | EP | disclosed |
| EP-1609360-A1 | Fungicidal Composition | Sumitomo Chemical Company, Limited (JP) | 2005-12-28 | — | — | EP | disclosed |
| US-20050282888-A1 | Fungicidal composition | SUMITOMO CHEMICAL COMPANY, LIMITED | 2005-12-22 | — | — | US | disclosed |
| EP-1577290-A1 | AMIDE COMPOUND AND METHOD OF CONTROLLING PLANT DISEASE WITH THE SAME | Sumitomo Chemical Company, Limited (JP) | 2005-09-21 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060122065-A1 | Amide compound and method of controlling plant disease with the same | CBR3, C5, CLN6 | CYP3A4 3014/4885TSHR 1117/4885ADRB2 3010/4885 |
| US-20060122064-A1 | Amides and method for plant diseases control with the same | ARG1, ARGLU1, ARG2 | CYP3A4 3215/4885TSHR 851/4885ADRB2 2260/4885 |
| US-20050282888-A1 | Fungicidal composition | DDT, CYP51A1, DDAH1 | CYP3A4 178/4885TSHR 3635/4885ADRB2 1828/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.